(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DOSAGEM

ArquivadaInvention PatentPCT · US2019057257

Application data

Number

112021007082

Type

Invention Patent

Filing

10/21/2019

Publication

08/03/2021

PCT

US2019057257

Progress at the INPI

  1. Filing10/21/19
  2. Publication08/03/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/21/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 04/18/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED

GB

See this company's full portfolio

Inventors

C. E. (pessoa física)

US

E. P. (pessoa física)

US

J. K. (pessoa física)

US

P. M. (pessoa física)

US

Technical data

Priority claims

US

62/748,595 · 10/22/2018

US

62/807,897 · 02/20/2019

US

62/837,385 · 04/23/2019

US

62/895,229 · 09/03/2019

US

62/902,444 · 09/19/2019

Abstract

DOSAGEM.A presente invenção refere-se a um método para o tratamento de câncer, que compreende administrar ao humano uma proteína de ligação a ICOS, ou uma porção de ligação ao antígeno da mesma, a uma dose entre aproximadamente 0,08 mg e 240 mg.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

04/18/2023

RPI 2728

Arquivamento - Art. 33 da LPI

#11.1

01/31/2023

RPI 2717

Notificação de entrada na fase nacional - PCT

#1.3

08/03/2021

RPI 2639

Alteração de dados cadastrais

#1.1

04/27/2021

RPI 2625

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.